FDA Inspection 856125 — NanoString, A Bruker Company
The FDA completed an inspection of NanoString, A Bruker Company on Nov 5, 2013 in Seattle, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 5, 2013
- Fiscal Year
- 2014
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Seattle, WA (United States)